Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |